Baxter Healthcare Renal Div Baxter Healthcare Corporation, RenalSoft Observational Study v.2.0 - HD Module, PD Module and Medical Record Module; clinical data management software; Baxter Healthcare Corporation, McGaw Park, Illinois 60085 Recall
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
Baxter Healthcare Corporation, RenalSoft Observational Study v.2.0 - HD Module, PD Module and Medical Record Module; clinical data management software; Baxter Healthcare Corporation, McGaw Park, Illinois 60085
Brand
Baxter Healthcare Renal Div
Lot Codes / Batch Numbers
version 2.0 - HD Modules, PD Modules and Medical Record Modules only
Products Sold
version 2.0 - HD Modules, PD Modules and Medical Record Modules only
Baxter Healthcare Renal Div is recalling Baxter Healthcare Corporation, RenalSoft Observational Study v.2.0 - HD Module, PD Module and Medica due to Software Error: There are software discrepancies that may increase the possibility of a medication error if the dialysis clinic software is used to tr. Based on FDA medical device recall database.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
Software Error: There are software discrepancies that may increase the possibility of a medication error if the dialysis clinic software is used to track, record, or coordinate the administration of medications.
Recommended Action
Per FDA guidance
Baxter sent Urgent Device Correction letters dated 3/29/06 to those customers who had their RenalSoft and Renal Software Suite software configured with the affected modules. The letters indicated in a table which software anomalies were associated with the affected software modules in each software version. A description of each anomaly was provided, along with interim actions to take to mitigate the anomaly until the new software version RenalSoft V.2.0.x can be issued. Individual customer training will be performed at each facility for those issues identified in the letter specific to their software version. At that time the mitigation provided in the letter will be reviewed with the customer.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticePage updated: Jan 10, 2026